Dr. Steve Targum
MD
Chief Medical Advisor
Dr Targum is an Executive-in-Residence at Oxford Bioscience Partners, where he advises portfolio companies in CNS drug development. In addition, he consults widely to the pharmaceutical industry regarding the design and implementation of clinical trials for new psychotropic drugs and the progression of drug development from concept to approval to launch. Dr. Targum founded PharmaStar, a global rater training and medical education company focused on CNS drug development and international clinical trials. Previously, Dr. Targum was Professor of Psychiatry and Vice-Chairman of the Department of Mental Health Sciences at Hahnemann University School of Medicine (Philadelphia) from 1989-1995.
Dr. Jeffrey L.Cummings (Chairman) - UCLA Alzheimer‘s Disease Center
Dr. Craig W.Ritchie - Imperial College London
Dr. Steven D. Targum - Oxford Bioscience Partners **
Professor Jean-Marc Orgogozo - University of Bordeaux
Professor Ashley Bush - Mental Health Research Institute
Professor Colin Masters - The University of Melbourne
Professor Rudolph Tanzi - Harvard Medical School, Massachusetts General Hospital
|
